Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

[1]  J. Moore,et al.  Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site. , 1992, AIDS research and human retroviruses.

[2]  R. Weiss,et al.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus , 1991, Virology.

[3]  J. Moore,et al.  Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2. , 1991, Virology.

[4]  D. Ho,et al.  Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody , 1991, Journal of virology.

[5]  J. Sodroski,et al.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.

[6]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[7]  Peter D. Kwong,et al.  Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.

[8]  Q. Sattentau,et al.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.

[9]  Q. Sattentau,et al.  Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding , 1990, The Journal of experimental medicine.

[10]  J. Moore,et al.  HIV-1 envelope protein gp120 expression by secretion in E. coli: assessment of CD4 binding and use in epitope mapping. , 1990, Journal of virological methods.

[11]  K. Steimer,et al.  Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. , 1990, AIDS research and human retroviruses.

[12]  B. Moss,et al.  Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells , 1990, Journal of virology.

[13]  J. Moore,et al.  Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. , 1990, AIDS.

[14]  R. Weiss,et al.  The pH independence of mammalian retrovirus infection. , 1990, The Journal of general virology.

[15]  J. Moore.  Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. , 1990, AIDS.

[16]  B. Seed,et al.  A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site , 1990, Cell.

[17]  T. Kieber‐Emmons,et al.  The gp120-CD4 interface: structural, immunological and pathological considerations. , 1989, Biochimica et biophysica acta.

[18]  R. Weiss,et al.  Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. , 1989, The Journal of general virology.

[19]  Q. Sattentau,et al.  Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes , 1989, The Journal of experimental medicine.

[20]  M. Emerman,et al.  Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding , 1989, Journal of virology.

[21]  T. H. Lee,et al.  Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[22]  Michael Emerman,et al.  Single amino-acid changes in HIV envelope affect viral tropism and receptor binding , 1989, Nature.

[23]  Q. Sattentau,et al.  Identification of the residues in human CD4 critical for the binding of HIV , 1989, Cell.

[24]  W. Dolmans,et al.  Prevalence of HIV-1 antibody among groups of patients and healthy subjects from a rural and urban population in the Mwanza region, Tanzania. , 1989, AIDS.

[25]  J. Moore,et al.  An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. , 1989, AIDS.

[26]  A. Fauci,et al.  Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. , 1988, Journal of immunology.

[27]  G. Nakamura,et al.  Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies , 1988, Journal of virology.

[28]  M. Skinner,et al.  Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4 , 1988, Journal of virology.

[29]  E. Reinherz,et al.  Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding , 1988, Nature.

[30]  B. Seed,et al.  Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4 , 1988, Cell.

[31]  R. Weiss,et al.  Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Q. Sattentau,et al.  The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. , 1988, AIDS.

[33]  R. Weiss,et al.  Neutralizing monoclonal antibodies to the AIDS virus. , 1988, AIDS.

[34]  M. Marsh,et al.  Human immunodeficiency virus infection of CD4‐bearing cells occurs by a pH‐independent mechanism. , 1988, The EMBO journal.

[35]  R. Axel,et al.  soluble form of CD4 (T4) protein inhibits AIDS virus infection , 1988, Nature.

[36]  J. Sodroski,et al.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. , 1987, Science.

[37]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[38]  W. Gallaher,et al.  Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus , 1987, Cell.

[39]  Edgar G. Engleman,et al.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane , 1987, Cell.

[40]  R. Schooley,et al.  Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins , 1987, Journal of virology.

[41]  A. Dalgleish,et al.  Variable and conserved neutralization antigens of human immunodeficiency virus , 1986, Nature.

[42]  R. Gallo,et al.  Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Mcdougal,et al.  Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. , 1986, Journal of immunology.

[44]  L. Arthur,et al.  Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Robin A. Weiss,et al.  Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients , 1985, Nature.

[46]  J. Levy,et al.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.

[47]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[48]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Bonner,et al.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. , 1974, European journal of biochemistry.

[50]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[51]  T. Schulz,et al.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? , 1991, AIDS research and human retroviruses.

[52]  J. Sodroski,et al.  Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. , 1990, Journal of acquired immune deficiency syndromes.

[53]  J. Moore,et al.  Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro. , 1990, AIDS research and human retroviruses.

[54]  J. Hall,et al.  Production of IgA-secreting rat X rat hybridomas. , 1986, Methods in enzymology.

[55]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[56]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[57]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .